Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent

Oct 03 2018

• By Eileen Francis

Related Content

Smaller OTC Loperamide Packages Wait As Retailers Limit Purchase Amounts

May 15 2018

Perrigo's OTC Core Could Expand To Include National Brands

Aug 10 2018

Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo

Jan 03 2018

Related Companies

Perrigo Company PLC

Johnson & Johnson

Merck & Co., Inc.

Additional Topics

United States Approvals Advertising, Marketing & Sales Launches FDA Generic Drugs OTC Drugs Respiratory Consumer

More from Products

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window